Trigeminal neuralgia affects roughly 25 to 50 people per 100,000 in any given year, depending on which population you study and how diagnoses are counted. That makes it uncommon enough that many doctors go years without seeing a case, yet not so vanishingly rare that it belongs in the “one-in-a-million” category reserved for the most exotic conditions. The complication is that these numbers are almost certainly an undercount, because trigeminal neuralgia is misdiagnosed so often that the true burden may be substantially higher than what registries capture.
The Numbers Vary More Than You Would Expect
A 2025 systematic review pooling data from studies conducted between 1945 and 2024 estimated the global incidence at about 25 cases per 100,000 person-years, with an annual prevalence of roughly 45 per 100,000 and a lifetime prevalence of around 108 per 100,000.1PubMed Central. Global Incidence and Prevalence of Trigeminal Neuralgia, 1945–2024: A Systematic Review and Meta-Regression Analysis Those figures suggest that roughly one in every 1,000 people will experience trigeminal neuralgia at some point in their life. But the confidence intervals around those pooled numbers are wide, which reflects genuine disagreement between studies from different countries and eras.
A population-based study in central Sweden, for instance, found an incidence of just 5.5 per 100,000 person-years, with rates climbing steeply by age and women affected about twice as often as men.2PubMed. Incidence of trigeminal neuralgia: A population-based study in Central Sweden Meanwhile, a Korean study using national electronic health data reported an incidence of about 100 per 100,000 in 2018, with the same female predominance but numbers roughly 20 times higher than Sweden’s.3PubMed Central. Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea
That gap is too large to be explained by biology alone. Part of it comes down to methodology: studies that rely on diagnostic billing codes in insurance databases tend to capture more cases, including milder ones, than studies that require specialist-confirmed diagnoses. Different coding systems, different thresholds for who sees a neurologist, and different levels of healthcare access all push the numbers around. The takeaway is that trigeminal neuralgia is not ultra-rare in the way many patients are told when they first look it up, but it is uncommon enough that finding a doctor with real experience managing it can be a challenge, especially outside major medical centers.
Who Gets It
Trigeminal neuralgia overwhelmingly favors people in middle age and beyond. In the Swedish data, incidence was nearly nonexistent in people under 20 and climbed to about 23 per 100,000 in those over 80.2PubMed. Incidence of trigeminal neuralgia: A population-based study in Central Sweden The Korean data pointed to the 51-to-59 age bracket as the peak.3PubMed Central. Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea Across nearly every study, women outnumber men by roughly two to one.
Why the female skew exists is not entirely clear. Hormonal influences, differences in pain-pathway sensitization, and healthcare-seeking patterns have all been proposed, but none has been confirmed as the primary driver. What is clear is that if you are a woman over 50 experiencing electric-shock-like jolts in your face, trigeminal neuralgia should be on the short list of possibilities, not dismissed as rare.
The Misdiagnosis Problem
Trigeminal neuralgia’s apparent rarity is tangled up with how often it gets missed entirely. The pain typically strikes in the cheek, jaw, or gums, and the first instinct for most people experiencing sudden, severe facial pain is to see a dentist. In one retrospective study, about 85 percent of trigeminal neuralgia patients were initially misdiagnosed and treated by dentists for dental pain, and more than half of those underwent at least one tooth extraction. The vast majority, over 90 percent, saw no improvement in pain after the procedure.4PubMed Central. Misdiagnosis-Driven Dental Extractions in Patients with Trigeminal Neuralgia: A Retrospective Study
That finding is consistent across multiple studies. A survey of trigeminal neuralgia patients who eventually underwent surgery found that about 82 percent had initially consulted their dentist, and more than half of those received invasive dental treatments including extractions, root canals, and implants before the true diagnosis was made.5PubMed. Unnecessary dental procedures as a consequence of trigeminal neuralgia Another study found that roughly two-thirds of patients visited a dentist for their trigeminal neuralgia pain, with an average of 1.6 teeth extracted per person before the condition was correctly identified.6PubMed Central. Please spare my teeth! Dental procedures and trigeminal neuralgia
The diagnostic delay varies enormously by setting. A European multicenter study found an average gap of about seven months between symptom onset and correct diagnosis.7PubMed Central. Pitfalls in recognition and management of trigeminal neuralgia In the Brazilian public health system, where specialist access is more limited, the delay ranged from weeks to 22 years, with a mean of about four and a half years.8Brazilian Journal of Oral Sciences. Trigeminal neuralgia: diagnosis delay and unnecessary dental procedures in the brazilian public health system Those years matter. Every month of misdiagnosis is a month of unnecessary dental work, ineffective treatment, and severe pain.
This pattern raises an uncomfortable question about the incidence numbers themselves. If many patients spend years bouncing between dentists and general practitioners before anyone thinks to consider a neurological cause, how many never get diagnosed at all? The “rarity” of trigeminal neuralgia may partly reflect a diagnostic blind spot rather than a genuinely low rate of occurrence.
What Causes It and How It Is Classified
The pain of trigeminal neuralgia is characteristically brief and electric. Clinical guidelines describe it as lancinating, unilateral, and typically lasting no more than two minutes per episode, though attacks can repeat many times per day.9PubMed Central. Idiopathic Facial Pain Syndromes–An Overview and Clinical Implications That brevity is part of what makes it confusing: between attacks, the person may feel perfectly fine, which can lead both patients and clinicians to underestimate what is happening.
The condition is classified into three types. The classical form, accounting for about 75 percent of cases, results from a blood vessel pressing against the trigeminal nerve root where it exits the brainstem. The secondary form, about 15 percent, is caused by an identifiable neurological disease such as a tumor or multiple sclerosis. The remaining roughly 10 percent are idiopathic, meaning no cause can be identified despite thorough investigation.10PubMed Central. Trigeminal neuralgia: a practical guide
In the classical form, the core problem is neurovascular compression. An artery or vein presses on the trigeminal nerve root, gradually damaging the protective myelin sheath around the nerve fibers.11Nature Reviews Disease Primers. Trigeminal neuralgia Pathology studies have shown that in the compressed region, demyelinated nerve fibers end up packed closely together without the insulating glial tissue that normally separates them. That close apposition allows abnormal electrical cross-talk between fibers, so a harmless touch to the face can trigger a burst of pain signaling.12Brain. Trigeminal neuralgia: Pathology and pathogenesis The same type of focal demyelination has been found in multiple sclerosis patients who develop trigeminal neuralgia, which is why MS is one of the identified secondary causes.
One nuance worth knowing: neurovascular contact (a vessel simply touching the nerve) is surprisingly common even in people who have no facial pain at all. One study found such contact in about 28 percent of control subjects without trigeminal neuralgia, compared to 80 percent of those with the condition.13PubMed Central. Trigeminal neuralgia: When does neurovascular contact turn into a conflict? So the mere presence of a vessel near the nerve is not enough to cause the disease. Something about the degree of compression, the angle of contact, or the individual’s vulnerability to demyelination tips the balance from harmless anatomical proximity to agonizing pain.
The Multiple Sclerosis Connection
Among people with multiple sclerosis, trigeminal neuralgia is far more common than in the general population. A meta-analysis pooling data from over 30,000 MS patients found a trigeminal neuralgia prevalence of about 3.4 percent, with rates slightly higher in women than men.14PubMed. Prevalence of trigeminal neuralgia in multiple sclerosis: A systematic review and meta-analysis That is dozens of times higher than in the general population.
The relationship runs both directions in time. In a large survey of MS patients, about 15 percent of those who reported trigeminal neuralgia said the facial pain had been diagnosed before their MS was.15PubMed Central. Trigeminal Neuralgia Commonly Precedes the Diagnosis of Multiple Sclerosis This means that for some patients, trigeminal neuralgia serves as an early red flag. If someone develops trigeminal neuralgia at an unusually young age or presents with features atypical for the classical form, brain MRI is recommended in part to screen for MS lesions.
Is There a Genetic Component?
Most trigeminal neuralgia is sporadic, meaning it appears in individuals with no known family history. The familial form accounts for an estimated 1 to 2 percent of cases.16PubMed Central. Trigeminal neuralgia and genetics: A systematic review But those rare family clusters have provided a window into which genes might contribute to susceptibility.
Whole-exome sequencing in families with multiple affected members has turned up variants in ion channel genes, particularly sodium, potassium, and calcium channels that control how nerve cells fire.17PubMed Central. Familial trigeminal neuralgia – a systematic clinical study with a genomic screen of the neuronal electrogenisome A specific mutation in a channel called TRPM7 has been linked to familial cases and shown to make trigeminal ganglion neurons more excitable than normal in laboratory models.18PubMed Central. A TRPM7 mutation linked to familial trigeminal neuralgia: Omega current and hyperexcitability of trigeminal ganglion neurons These findings are still early-stage, and no genetic test exists for trigeminal neuralgia. But they suggest that some people may carry variants that make their trigeminal nerve fibers inherently more prone to the kind of hyperexcitability that produces attacks, which could explain why not everyone with neurovascular compression develops the disease.
Mental Health and the “Suicide Disease” Label
Trigeminal neuralgia has been called the “suicide disease” for decades, a label that sounds melodramatic until you look at the data behind it. A nationwide Swedish study that followed over 3,500 trigeminal neuralgia patients for a median of more than 17 years found that the risk of intentional self-harm was about twice that of the general population. Among women with the condition, the suicide risk was two and a half times higher. The study’s authors explicitly supported the characterization of trigeminal neuralgia as a disease that can drive people to suicidal behavior.19PubMed Central. Trigeminal neuralgia is associated with increased risk of cerebrovascular disease, myocardial infarction and suicide – a nationwide Swedish study
The same study found elevated risks of stroke and heart attack among trigeminal neuralgia patients. Male patients were more likely to experience heart attack and ischemic stroke, while women faced higher risks of self-harm and accidental poisoning. Overall mortality was not increased, meaning the condition is not killing people broadly, but it is damaging their health and quality of life through specific, measurable pathways.
Survey data paint a picture of a population under severe psychological strain. In one study of trigeminal neuralgia patients, about 39 percent had elevated anxiety and about 29 percent had elevated depression. Suicidal thinking was significantly worse among those with higher levels of anxiety and depression.20PubMed Central. Suicidal Ideation and Self-Injury in Trigeminal Neuralgia These numbers are worth taking seriously when discussing how “rare” the disease is. A condition that affects perhaps one in 1,000 people over a lifetime and carries a doubled suicide risk is not merely a curiosity. Rarity does not mean low impact.
The Economic Toll
Beyond the personal suffering, trigeminal neuralgia creates real economic consequences for the people who have it. A study of patients treated with medication in family practice found that the condition was associated with substantial healthcare costs from emergency visits, imaging, and specialist consultations, as well as lost workdays.21PubMed. Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction Among patients who eventually went on to surgery, the majority reported feeling strongly handicapped in their productivity beforehand, with an average of 21 pain-related days off work per year. After successful surgery, that dropped to about four days.22PubMed. Working ability and use of healthcare resources for patients with trigeminal neuralgia treated via microvascular decompression
These costs stack up across the years-long diagnostic delays many patients experience. Someone who spends three or four years getting unnecessary dental work, trying medications for the wrong diagnosis, and losing workdays to uncontrolled pain accumulates significant out-of-pocket expenses and lost earnings before anyone figures out what is actually wrong.
When It Hits Young People
Trigeminal neuralgia in people under 30 is genuinely rare, but it happens. A case series of patients whose symptoms began before age 25 found an average onset age of about 20, with all cases involving venous (rather than arterial) compression of the trigeminal nerve. Outcomes after surgery were mixed, with only about half achieving good pain relief.23PubMed. Trigeminal neuralgia in young adults A separate series with onset as young as 14 found that a wider range of vascular causes were at play, including arterial and combined arterial-venous compression. Long-term outcomes were more encouraging in this group, with most patients achieving excellent results after microvascular decompression.24PubMed. Young-onset trigeminal neuralgia: a clinical study and literature review
Young-onset trigeminal neuralgia tends to raise immediate suspicion for secondary causes, particularly multiple sclerosis. But these case series show that classical neurovascular compression can occur in younger patients too, and that surgical outcomes vary. One common thread is a long lag between the start of symptoms and surgery, averaging about five years in one of these series, likely because clinicians and patients alike struggle to believe the diagnosis at such a young age.
Triggers You Might Not Expect
Most people who know anything about trigeminal neuralgia associate it with touch-triggered pain: a light brush against the cheek, chewing, or even talking can set off an attack. But a study examining atypical triggers found that about 20 percent of patients reported weather-related triggers, including strong winds and cold temperatures, and about 25 percent identified specific foods as triggers, particularly hard or tough foods, and to a lesser extent hot, cold, or spicy ones.25PubMed Central. Atypical triggers in trigeminal neuralgia: the role of A-delta sensory afferents in food and weather triggers
The proposed explanation is that these seemingly different triggers share a common pathway through certain nerve fibers that respond to temperature, pressure, and chemical stimuli. For patients, this matters practically: someone who only expects mechanical triggers may not connect cold windy weather or biting into a hard apple with their condition. Recognizing these patterns can help patients avoid attacks and can also help clinicians distinguish trigeminal neuralgia from other types of facial pain.
Bilateral Trigeminal Neuralgia
Trigeminal neuralgia almost always affects one side of the face. Having it strike both sides is uncommon enough that when it does happen, it usually arrives in sequence rather than simultaneously. A study of 34 patients with bilateral trigeminal neuralgia found that the average age when the first side began hurting was about 50, with the opposite side following at about age 58.26PubMed. Sequential onset of bilateral trigeminal neuralgia: clinical presentation and outcomes The gap of several years between sides is the norm, and simultaneous bilateral pain should prompt an especially thorough workup for secondary causes like MS or a tumor.
Bilateral cases create unique treatment challenges, because surgical options that work well on one side carry additional risk when repeated on the other. For patients already dealing with the psychological burden of unilateral disease, the prospect of the other side flaring up years later is a source of particular dread.
What Happens When Surgical Treatment Fails
Microvascular decompression, the surgery that physically moves the offending blood vessel away from the trigeminal nerve, is the most definitive treatment for classical trigeminal neuralgia. But pain can recur. A study comparing different approaches to recurrent trigeminal neuralgia after an initial surgery found that five-year recurrence rates were significantly higher than one-year rates across all treatment strategies. Repeat surgery through a second craniotomy showed the lowest five-year recurrence rate compared to other salvage options.27PubMed. Treatment of recurrent trigeminal neuralgia after microvascular decompression: How to select An analysis of patients who underwent secondary procedures after initial treatment failure found that about 92 percent still achieved good outcomes, which is reassuring for patients who fear that a failed first surgery means they are out of options.28PubMed Central. A Clinical Analysis of Secondary Surgery in Trigeminal Neuralgia Patients Who Failed Prior Treatment
The broader point is that trigeminal neuralgia management is often iterative. A first-line medication like carbamazepine works for many people initially but can lose effectiveness over time or cause intolerable side effects. Surgery is highly effective but not always permanent. The disease may be uncommon, but for the people who have it, the treatment journey is frequently long and requires access to specialists who understand the full range of medical and surgical options. That access remains uneven, especially for patients in rural areas or health systems where trigeminal neuralgia is treated as too rare to warrant specialized care infrastructure.